 |
| On the 26th, when AstraZeneca (AZ) vaccination began, nursing care workers who completed vaccination against the novel coronavirus infection (Corona 19) at the Seongdong-gu Health Center in Seoul are waiting in the adverse reaction observation room after vaccination. 2021.2.26/News1 © News1 Reporter Park Ji-hye |
A total of 112 cases (persons) as of 0 o’clock on the 28th were counted as cases of adverse reactions after vaccination against the novel coronavirus infection (Corona 19) vaccine. After the first day of vaccination, 15 cases were added, 97 cases were added on the last 7 days, increasing to 112 cases.
According to the Centers for Disease Control and Prevention of the Korea Centers for Disease Control and Prevention on the 28th, as of 0 o’clock on the day, the number of adverse reactions to those who were vaccinated for Corona 19 increased by 97 to a cumulative 112 cases. Of the 97 new adverse reactions, 96 AstraZeneca vaccines and 1 Pfizer vaccine.
As the AstraZeneca vaccine is being vaccinated on the 3rd day from the 26th, 111 out of 112 cases are the AstraZeneca vaccine. However, the number of AstraZeneca vaccinations was 22,22 and Pfizer was 300, showing a big difference.
“A total of 112 cases were reported as being suspected of adverse reactions after the COVID-19 vaccination,” said Bang Dae-bon. “All were mild cases such as headache, fever, nausea, and vomiting that can be common after vaccination.”
The first priority target for AstraZeneca vaccination is 280,980 people who are residents and workers in nursing hospitals and nursing facilities under the age of 65. The priority recipients of the Pfizer vaccine are 54,910 medical staff who treat patients with COVID-19. Among them, 300 people, including 199 workers at the National Medical Center and 101 workers at Corona 19 treatment hospitals in the metropolitan area, received the vaccine on the 27th.
Pfizer vaccine will be vaccinated first at the Central Vaccination Center until this week, and from March 3, the second week, the vaccination center will be expanded to regional and Daegu vaccination centers. The supply amount is 64,400 DOS for the Central Vaccination Center of the National Medical Center, and the area is 164,000 DOS for Soonchunhyang University Cheonan Hospital, 19900 DOS for Busan National University Yangsan Hospital, 15,000 DOS for Chosun University Hospital, and 59,000 DOS for Keimyung University Daegu Dongsan Hospital.
The current status of the first vaccination of the vaccine, plus AstraZeneca vaccine and Pfizer vaccine, by region was 2417 in Seoul, 631 in Busan, 368 in Daegu, 915 in Incheon, 3274 in Gwangju, 417 in Daejeon, 200 in Ulsan, 40 in Sejong, Gyeonggi 4067 people, Gangwon 750, Chungbuk 847, Chungnam 1569, Jeonbuk 1103, Jeonnam 1950, Gyeongbuk 399, Gyeongnam 1096, and Jeju 279.